Anemocyte is a BMO - Biotech Manufactoring Organization, a lead innovator in the field of Advanced Therapies. A dynamic reality, driving force behind projects aiming to truly improve the quality of our lives. A solid organization, thanks to its strong scientific, technical, regulatory expertise, moved by a deep passion for life, today Anemocyte is the place where the Therapies of tomorrow are born. Anemocyte does not stand alone in its pursuit, as it is part of the Nine Trees Group. Over sixty years of experience, serving the pharmaceutical industry worldwide, Nine Trees Group is an international reality able to combine with passion transversal competences in chemistry and biology, in accordance with the highest international standards. Anemocyte provides quality driven innovative solutions for Advanced Therapies, like: Cell Therapy Platform Manufacturing of autologous and allogeneic products. DNA Platform Plasmid DNA for vaccination or viral vector production. Gene Therapy Platform Process Development and implementation for viral vector and gene modified cells in our I&D unit. What drives our talents is the love for innovation, the commitment and dedication to constantly improve the quality of the patients’ lives. Our talents are here to restore life, creating a new future. Find out more at: www.anemocyte.com